Screener
Maravai LifeSciences Holdings, Inc. MRVI Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $51.44M+8.5% | $65.84M+40.5% | $49.87M-11.8% | $41.63M-39.7% | $47.4M-31.7% | ||
| $30.79M-22.3% | $32.14M-17.9% | $37.02M-0.4% | $35.98M-2.2% | $39.63M+2.7% | ||
| $20.65M+166% | $33.7M+336% | $12.84M-33.8% | $5.66M-82.5% | $7.77M-74.8% | ||
| 40.1%+23.8pp | 51.2%+34.7pp | 25.8%-8.5pp | 13.6%-33.1pp | 16.4%-28.0pp | ||
| $3.7M-24.2% | $3.89M-20.4% | $3.79M-16.9% | $3.84M-18.3% | $4.88M-0.9% | ||
| $32.07M-17.2% | $29.09M-26.5% | $31.58M-23.4% | $35.4M-9.4% | $38.72M-4.5% | ||
| $35.74M-51.7% | $35.86M-37.0% | $71.64M+25.5% | $46.69M-76.4% | $74.05M-10.6% | ||
| -$15.09M+77.2% | -$2.16M+95.6% | -$58.8M-55.9% | -$41.03M+75.2% | -$66.28M-393% | ||
| -29.3%+111pp | -3.3%+102pp | -117.9%-51.2pp | -98.6%+141pp | -139.8%-120pp | ||
| $4.81M-29.4% | $5.75M-15.2% | $6.56M-41.8% | $6.84M-49.8% | $6.82M-42.9% | ||
| -$52K+98.7% | -$494K-2,158% | -$43K— | -$71K-199% | -$4.06M-58.5% | ||
| -$21.8M+70.6% | -$6.53M+87.6% | -$63.01M-36.8% | -$45.15M+73.8% | -$74.13M-255% | ||
| -$171K+96.0% | -$151K-193% | $0+100% | -$92K-130% | -$4.29M-76.1% | ||
| -$12.42M+68.6% | -$3.73M+87.5% | -$35.68M-37.7% | -$25.56M+73.7% | -$39.59M-304% | ||
| -24.1%+59.4pp | -5.7%+58.2pp | -71.6%-25.8pp | -61.4%+79.2pp | -83.5%-69.4pp | ||
| -$0.08+70.4% | -$0.02+90.5% | -$0.24-33.3% | -$0.18+73.5% | -$0.27-286% | ||
| -$3.31M+93.8% | $9.21M+125% | -$46.35M-83.0% | -$27.85M+81.9% | -$53.12M-5,134% | ||
| -6.4%+106pp | 14%+91.8pp | -92.9%-48.2pp | -66.9%+156pp | -112.1%-111pp | ||
| -$15.09M+77.2% | -$2.16M+95.6% | -$58.8M-55.9% | -$41.03M+75.2% | -$66.28M-393% |
FAQ
- What is Maravai LifeSciences Holdings, Inc.'s revenue?
- Maravai LifeSciences Holdings, Inc. (MRVI) generated $208.8M in revenue over the trailing twelve months, down 5.0% year over year.
- Is Maravai LifeSciences Holdings, Inc. profitable?
- Maravai LifeSciences Holdings, Inc. is not currently profitable: it reported a net loss of $77.4M over the trailing twelve months, a -37.1% net margin.
- What are Maravai LifeSciences Holdings, Inc.'s profit margins?
- Gross margin is 34.9% and operating margin is -56.1%, with a -37.1% net margin.
- What is Maravai LifeSciences Holdings, Inc.'s earnings per share?
- Maravai LifeSciences Holdings, Inc.'s diluted EPS over the trailing twelve months is $-0.52.
- Where does Maravai LifeSciences Holdings, Inc.'s income statement data come from?
- Every line is extracted from Maravai LifeSciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
